Connective tissue disease | VEGF-A (pg/ml) | TNFα (pg/ml) | IL1β (pg/ml) |
---|---|---|---|
RS3PE syndrome, remitting seronegative symmetrical synovitis with pitting oedema syndrome; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; MCTD, mixed connective tissue disease; PM/DM, polymyositis/dermatomyositis. | |||
Data are mean (SD) of the indicated number of patients. | |||
*p<0.0001 v other connective tissue diseases by Student’s t test. | |||
RS3PE syndrome (n = 3) | 2223.3 (156.3)* | 26.3 (20.8) | 0.67 (0.81) |
RA (n = 12) | 711.0 (401.7) | 19.9 (13.7) | 0.61 (0.39) |
SLE (n = 10) | 309.9 (140.6) | 34.2 (19.4) | 0.32 (0.16) |
MCTD (n = 6) | 682.3 (575.0) | 51.8 (27.7) | 0.48 (0.39) |
PM/DM (n = 13) | 324.2 (188.9) | 22.6 (10.9) | 0.32 (0.24) |
Vasculitis syndrome (n = 13) | 736.1 (475.5) | 27.3 (14.2) | 0.90 (1.38) |